1-4 of 4
Yu Ping
Close
Sort by
Journal Articles

CD19/BCMA Dual-Targeting Fastcar-T GC012F for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: An Update

Xinfeng Chen, Yu Ping, Ling Li, Lei Zhang, Xudong Zhang, Jianmin Huang, Jia Liu, Gui Li, Huan Shi, Jiaping He, Yi Liang, Lihong Weng, Wenjie Yin, Lianjun Shen, Wei William Cao, Wenling Li, Mingzhi Zhang, Yi Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6847.
https://doi.org/10.1182/blood-2023-185476
Published: 2023
Journal Articles

The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint Inhibitors

Ting-Bo Liu, Xiaofan Li, Rui-Zhi Zhao, Han Shao, Gui-Qing Shi, Yan-Yan Qiu, Tian-Lan Tang, Yu-Ping Lin, Si-Lin Chen, Cheng Huang, Si-Qin Liao, Jin-Hua Chen, Hai-Ying Fu, Jian-Zhi Liu, Jian-Zhen Shen, Ben-Hua Xu, Yu-jing Zhang, Yong Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6189.
https://doi.org/10.1182/blood-2023-184773
Published: 2023
Journal Articles

Phase I/II, Randomized, MultiCenter, Dose-Ascension Study of the p38MAPK Inhibitor Scio-469 in Patients with Myelodysplastic Syndrome (MDS).

Lubomir Sokol, MD, PhD, Larry Cripe, M.D., Hagop Kantarjian, M.D., Mikkael A. Sekeres, M.D., Simrit Parmar, M.D., Peter Greenberg, M.D., Stuart Goldberg, M.D., Vikas Bhushan, M.D., Jamile Shammo, M.D., Raymond Hohl, M.D., Ph.D., Yu-Ping Li, Ph.D., Ann Lowe, M.D., Joy Zhu, M.D., Alan List, M.D.
Journal: Blood
Blood (2006) 108 (11): 2657.
https://doi.org/10.1182/blood.V108.11.2657.2657
Published: 2006
Journal Articles

Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis

Yu-Ping Xia, Baosheng Li, Donna Hylton, Michael Detmar, George D. Yancopoulos, John S. Rudge
Journal: Blood
Blood (2003) 102 (1): 161–168.
https://doi.org/10.1182/blood-2002-12-3793
Published: 2003